Hidradenitis Suppurativa
7 competing products in clinical development for Hidradenitis Suppurativa.
Pipeline by Phase
Phase 23
Phase 34
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Sonelokimab | MoonLake Immunotherapeutics | Phase 3 | Recruiting | 41 |
| Sonelokimab | MoonLake Immunotherapeutics | Phase 3 | Recruiting | 41 |
| Eltrekibart + Placebo | Eli Lilly | Phase 2 | Active | 39 |
| Sonelokimab + Placebo | MoonLake Immunotherapeutics | Phase 3 | Active | 38 |
| Sonelokimab + Placebo | MoonLake Immunotherapeutics | Phase 3 | Active | 38 |
| Placebo + LY3041658 | Eli Lilly | Phase 2 | Completed | 35 |
| Sonelokimab (M1095) + Adalimumab | MoonLake Immunotherapeutics | Phase 2 | Completed | 29 |